Breast Cancer Research: Milestones


For every milestone in clinical trial for combination cancer sex hormones and help carry out their function.

1966 — Henry Lynch, MD, first identified a hereditary Herceptin-r improves survival of women with advanced breast cancer.

1999 — V. Craig Jordan, PhD, reported that raloxifene reduces the risk of breast cancer by 76% in postmenopausal women with osteoporosis.

2002 — Stephen Friend, MD, PhD, developed DNA technology to predict which breast cancer patients will develop metastasis, thus making aggressive chemotherapy a preventive measure.

2002 — Bernard Fisher, MD, published results of his 20-year study of 1,800 women: Total mastectomy offers no advantage over either lumpectomy or lumpectomy plus radiation therapy.

Umberto Veronesi, MD, researcher with the European Institute of Oncology in Milan, Italy, published the 20-year follow-up results of his study of 701 women who had either lumpectomy plus radiation therapy or radical mastectomy. The overall survival rate in the two groups was virtually identical.

The saga of breast cancer research, of course, has not ended. Many more names will be added to this list as dedicated people struggle to find answers to the complex disease called breast cancer.